Latest

• Report of the Russian database on adverse drug reactions for COVID-19-related drugs with a focus on favipiravir

  Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(1):26-33

• Safety profile assessment of drug products used for the pathogenetic treatment of COVID19

  Clinical Microbiology and Antimicrobial Chemotherapy. 2021; 23(3):314-329